MIR1973: A Drug Target / Disease Biomarker (G100302290)
MIR1973: A Drug Target / Disease Biomarker
MIR1973, also known as interleukin-18 (IL-18), is a protein that is expressed in various tissues throughout the body. It is a key regulator of immune and inflammatory responses and has been implicated in a number of diseases, including cancer, autoimmune disorders, and obesity.
One of the key functions of MIR1973 is its role in the regulation of inflammation. MIR1973 has been shown to play a key role in the recruitment of immune cells to the site of inflammation, as well as in the production of pro-inflammatory cytokines. This is important because chronic inflammation can contribute to a number of diseases, including heart disease, diabetes, and cancer.
Another function of MIR1973 is its role in cell signaling. MIR1973 has been shown to interact with a variety of intracellular signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. This is important because these pathways are involved in a wide range of cellular processes, including cell growth, differentiation, and inflammation.
MIR1973 is also of interest as a potential drug target. Because MIR1973 is involved in a wide range of cellular processes, it is a potential target for a variety of different drugs. For example, drugs that can inhibit MIR1973 activity have been shown to have potential therapeutic benefits in a wide range of diseases, including cancer, autoimmune disorders, and obesity.
In addition to its potential therapeutic applications, MIR1973 is also of interest as a potential biomarker. Because MIR1973 is expressed in a wide range of tissues, it may be a useful indicator of the level of inflammation in a particular tissue or the level of MIR1973 activity in a particular cell. This could be useful for the diagnosis and monitoring of a wide range of diseases, including cancer, autoimmune disorders, and obesity.
Overall, MIR1973 is a protein that has important roles in the regulation of inflammation and cell signaling. Its potential therapeutic applications and biomarker status make it an attractive target for further research and development.
Protein Name: MicroRNA 1973
The "MIR1973 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1973 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1976 | MIR198 | MIR199A1 | MIR199A2 | MIR199B | MIR19A | MIR19B1 | MIR19B2 | MIR200A | MIR200B | MIR200C | MIR200CHG | MIR202 | MIR202HG | MIR203A | MIR203B | MIR204 | MIR205 | MIR2052 | MIR2052HG | MIR2053 | MIR2054 | MIR205HG | MIR206 | MIR208A | MIR208B | MIR20A | MIR20B | MIR21 | MIR210 | MIR210HG | MIR211 | MIR2110 | MIR2113 | MIR2114 | MIR2115 | MIR2116 | MIR2117 | MIR212 | MIR214 | MIR215 | MIR216A | MIR216B | MIR217 | MIR217HG | MIR218-1 | MIR218-2 | MIR219A1 | MIR219A2 | MIR219B | MIR22 | MIR221 | MIR222 | MIR223 | MIR224 | MIR2276 | MIR2277 | MIR2278 | MIR22HG | MIR2355 | MIR2392 | MIR23A | MIR23AHG | MIR23B | MIR23C | MIR24-1 | MIR24-2 | MIR2467 | MIR25 | MIR2681 | MIR2682 | MIR26A1 | MIR26A2 | MIR26B | MIR27A | MIR27B | MIR28 | MIR2861 | MIR2909 | MIR296 | MIR297 | MIR298 | MIR299 | MIR29A | MIR29B1 | MIR29B2 | MIR29B2CHG | MIR29C | MIR300 | MIR301A | MIR301B | MIR302A | MIR302B | MIR302C | MIR302D | MIR302E | MIR302F | MIR3059 | MIR3064 | MIR3065
